[aaavl2821]

China has one big advantage vs the US when it comes to future innovation potential in biotech: a large cohort of talented young professionals being trained in drug discovery and development

Big pharma organizations in the US and Europe have been cutting r&d workforces for years, and most small biotech startups that are filling the innovation gap hire execs with 20+ years of experience to design and manage the research and outsourcing the actual work to china. Wuxi, a large contract research org in china, employs like 1-2,000 discovery chemists. I think Pfizer employs maybe 100